Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Health Catalyst, Inc. (HCAT : NSDQ)

• Company Description    Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. Number of Employees: 1,500

• Price / Volume Information    Yesterday's Closing Price: $3.13 Daily Weekly Monthly 20 Day Moving Average: 853,648 shares Shares Outstanding: 70.37 (millions) Market Capitalization: $220.27 (millions) Beta: 1.53 52 Week High: $9.24 52 Week Low: $2.52 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.01% 5.13% 12 Week -14.25% -22.11% Year To Date -55.73% -59.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10897 SOUTH RIVER FRONT PARKWAY #300 - SOUTH JORDAN,UT 84095 USA ph: 801-708-6800 fax: - ir@healthcatalyst.com http://www.healthcatalyst.com

• General Corporate Information    Officers Daniel Burton - Chief Executive Officer and Director Jason Alger - Chief Financial Officer John A. Kane - Director Duncan Gallagher - Director Jill Hoggard Green - Director Peer Information Health Catalyst, Inc. (HLIS) Health Catalyst, Inc. (AZTA) Health Catalyst, Inc. (APYI) Health Catalyst, Inc. (RNVA) Health Catalyst, Inc. (HMSY) Health Catalyst, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 42225T107 SIC: 7370 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/05/25 Share - Related Items Shares Outstanding: 70.37 Most Recent Split Date: (:1) Beta: 1.53 Market Capitalization: $220.27 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.23 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.63 Price/Cash Flow: 8.88 Price / Sales: 0.70 EPS Growth vs. Year Ago Period: -166.67% vs. Previous Quarter: 20.00% Sales Growth vs. Year Ago Period: 6.35% vs. Previous Quarter: 1.65% ROE 06/30/25 - -7.21 03/31/25 - -6.14 12/31/24 - -6.48 ROA 06/30/25 - -3.28 03/31/25 - -2.74 12/31/24 - -3.04 Current Ratio 06/30/25 - 1.83 03/31/25 - 1.24 12/31/24 - 1.43 Quick Ratio 06/30/25 - 1.83 03/31/25 - 1.24 12/31/24 - 1.43 Operating Margin 06/30/25 - -8.24 03/31/25 - -7.17 12/31/24 - -7.58 Net Margin 06/30/25 - -31.67 03/31/25 - -23.34 12/31/24 - -22.67 Pre-Tax Margin 06/30/25 - -31.53 03/31/25 - -23.20 12/31/24 - -22.56 Book Value 06/30/25 - 4.99 03/31/25 - 5.37 12/31/24 - 6.00 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.44 03/31/25 - 0.40 12/31/24 - 0.41 Debt-to-Capital 06/30/25 - 30.34 03/31/25 - 28.65 12/31/24 - 29.28

Powered by Zacks Investment Research ©